| D-peptide inhibitors of the p53–MDM2 interaction for targeted molecular therapy of malignant neoplasms M Liu, C Li, M Pazgier, C Li, Y Mao, Y Lv, B Gu, G Wei, W Yuan, C Zhan, ... Proceedings of the National Academy of Sciences 107 (32), 14321-14326, 2010 | 246 | 2010 |
| Development of mucoadhesive microspheres of acyclovir with enhanced bioavailability Y Tao, Y Lu, Y Sun, B Gu, W Lu, J Pan International journal of pharmaceutics 378 (1-2), 30-36, 2009 | 141 | 2009 |
| Fatty acid-based strategy for efficient brain targeted gene delivery J Shen, M Yu, Q Meng, J Li, Y Lv, W Lu Pharmaceutical research 30, 2573-2583, 2013 | 24 | 2013 |
| Imidazole-based pH-sensitive convertible liposomes for anticancer drug delivery R Huang, V Gyanani, S Zhao, Y Lu, X Guo Pharmaceuticals 15 (3), 306, 2022 | 9 | 2022 |
| Intrapulmonary inoculation of multicellular spheroids to construct an orthotopic lung cancer xenograft model that mimics four clinical stages of non-small cell lung cancer Y Huang, Y Lu, M Vadlamudi, S Zhao, M Felmlee, R Rahimian, X Guo Journal of Pharmacological and Toxicological Methods 104, 106885, 2020 | 8 | 2020 |
| Fliposomes with a pH-sensitive conformational switch for anticancer drug delivery against triple negative breast cancer Y Lu University of the Pacific Dissertation, 2019 | 1 | 2019 |
| Conformational switch-based pH-sensitive liposomes enhance the anticancer activity of doxorubicin on 3D multicellular spheroids Y Lu, S Zhao, X Guo | 1 | 2017 |
| Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs Z Xu, Y Huang, Y Zhu, X Pei, Y Lu, S Zhao, X Guo JoVE (Journal of Visualized Experiments), e66787, 2024 | | 2024 |
| Construction of An Orthotopic Xenograft Model of Non-small Cell Lung Cancer Mimicking Disease Progression and Predicting Drug Activities. Z Xu, Y Huang, Y Zhu, X Pei, Y Lu, S Zhao, X Guo Journal of Visualized Experiments: Jove, 2024 | | 2024 |
| Multicellular spheroids of A549 cells: A clinically relevant model of lung cancer X Pei, H Ling, Y Lu, M Vadlamudi, Y Huang, R Huang, S Zhao, Z Xu, ... Cancer Research 80 (16_Supplement), 312-312, 2020 | | 2020 |
| Development and Characterization of Clinically Relevant Non‐Small Cell Lung Cancer Mouse Model with Near‐Infrared Fluorescent 3D Spheroids Y Huang, Y Lu, M Vadlamudi, X Guo The FASEB Journal 33 (S1), 509.5-509.5, 2019 | | 2019 |
| Construction of Clinically Relevant Non-Small Cell Lung Cancer Model in Athymic Nude Mice using 3D Spheroids of A549-iRFP Cells Y Huang, Y Lu, M Vadalamudi, X Guo | | 2018 |
| Liposomal Magnesium Phosphate Nanoparticles for Intracellular Delivery of Catalase M Vadlamudi, P Naidu, Y Lu, H Gurrala, W Yue, X Guo | | 2017 |
| Doxorubicin-loaded liposomes with a pH-sensitive conformational switch for anticancer drug delivery Y Lu, X Guo, S Zhao, Y Zheng, N Samoshina, V Samoshin | | 2015 |
| Optimization of Doxorubicin-Loaded Anticancer Liposomes with a pH-Sensitive Conformational Switch Y Lu, S Zhao, X Guo | | 2015 |
| Optimization, in vitro and in vivo Evaluation of Mitothiorole Self-microemulsions PANJ Lü Yifan, SUN Yinjing, LI Jin, LU Weiyue Chinese Journal of Pharmaceuticals 41 (11), 836-840, 2010 | | 2010 |
| Drug delivery strategies for insoluble drugs Y LUI, W LU, J PAN World Clinical Drugs 30 (1), 41-45, 2009 | | 2009 |
